Unicoat Pharma ApS: Financial statements 2025
CVR: 37166707
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Unicoat Pharma ApS (CVR 37166707) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 867,952 and a net result of DKK 680,181 compared with DKK 638,057 the year before. That is an increase of 8.2% compared with the year before. Equity in the 2025 report amounted to DKK 507,241. The solvency ratio was 31.1%.
- Gross Profit
- DKK 867,952
- Profit/Loss
- DKK 680,181
- Equity
- DKK 507,241
- Total Assets
- DKK 1,630,319
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 868 t. | 680 t. | 507 t. | 0 |
| 2024 | - | 802 t. | 638 t. | 288 t. | 3 |
| 2023 | - | 988 t. | 777 t. | 577 t. | - |
| 2022 | - | 705 t. | 542 t. | 393 t. | - |
| 2021 | - | 689 t. | 535 t. | 290 t. | - |
Official annual report
How creditworthy is Unicoat Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Unicoat Pharma ApS has published its annual report for 2024. Gross profit came to DKK 801,870, and the net result was DKK 638,057.
About Unicoat Pharma ApS
Unicoat Pharma ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2015. The company is registered under the industry Overfladebehandling af metal. The management consists of Morten Clausen, Amanda Ryberg and Magnus Knorr Clausen. The company is owned by M C Holding ApS, MCVA Holding ApS and A Ryberg Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 867,952 and a net result of DKK 680,181 compared with DKK 638,057 the year before. Equity in the 2025 report amounted to DKK 507,241.